Prediction: Meta Stock Reclaims Its All-Time High Before 2029.

Meta stock is ~27% below its Aug. 12, 2025 record close of $790 (trading around ~$579). Q2 revenue rose 28% YoY to $60.8B, but costs jumped 55% to $42.0B, pulling operating margin to 31% (from 43%) and lowering diluted EPS 13% to $6.18; free cash flow also fell to $784M from $8.5B. The quarter included ~$2.4B in legal charges and ~$1.18B in severance, and Meta expects another ~$10B of legal expense in Q3 tied to a settlement of up to $16.7B (plus $1B with Texas). Despite the near-term drag, the article argues ads growth (impressions +14%, ad price +12%) could be enough to regain the $790 level by end-2028 without valuation multiple expansion.

Analysis

The market is treating this as a debate over capex efficiency, not top-line durability. That matters because Meta’s revenue engine is still strong enough that the stock can rerate higher even with flat-ish multiple expansion, but only if investors believe incremental AI spend converts into sustained ad pricing power rather than a prolonged drag on depreciation and FCF. The near-term loser is the balance sheet to earnings bridge: if spending stays this aggressive, the market will keep discounting future EPS more than current revenue growth justifies.

Second-order winners are the GPU and AI infrastructure vendors that capture the spend regardless of Meta’s eventual ROI; NVDA is the cleanest liquid proxy. On the competitive side, improved ad monetization at Meta is a headwind for smaller ad platforms and lower-quality traffic networks, because Meta can outbid them on advertiser ROI while still expanding impression volume. The settlement is actually mildly bullish in that it converts an open-ended legal overhang into a quantifiable expense, but it does not solve the harder issue: whether 2026-27 capex produces enough incremental cash flow before depreciation catches up.

The contrarian point is that consensus may be over-focusing on the absolute size of capex and underestimating operating leverage if ad pricing keeps compounding. The thesis breaks if expense growth remains materially above revenue into 2027, or if free cash flow fails to normalize after the settlement charge rolls off. Over the next 1-3 months, the key catalyst is whether management reiterates the AI spend trajectory without softening 2026 guidance; over 6-18 months, the proof will be in margin recovery, not the headline growth rate.

Key Decisions for Investors

• Buy META on any post-earnings or settlement-driven weakness, targeting a 6-12 month horizon; the risk/reward improves if the market over-discounts one-time legal charges versus recurring ad monetization.
• For investors wanting AI capex exposure with less balance-sheet/earnings volatility, pair long NVDA vs. short META on rallies over the next 1-3 months; this isolates infrastructure spend capture from Meta’s FCF uncertainty.
• Do not short META solely on the legal settlement headline; instead wait for confirmation that 2027 expense growth is still outpacing revenue growth. If that persists into the next two quarters, the long thesis weakens materially.
• Use a tactical alert: if Meta’s forward EPS estimates are cut again while capex guidance stays above $130B, fade the stock; if FCF rebounds meaningfully without a revenue deceleration, add to longs.